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Objective: Rupture after abdominal endovascular aortic aneurysm repair (EVAR) is a function of graft maintenance of the
seal and ﬁxation. We describe our 10-year experience with rupture after EVAR.
Methods: From 2000 to 2010, 1736 patients with abdominal aortic aneurysm (AAA) from 17 medical centers underwent
EVAR in a large, regional integrated health care system. Preoperative demographic and clinical data of interest were
collected and stored in our registry. We retrospectively identiﬁed patients with postoperative rupture, characterized as
“early” and “delayed” rupture (#30 days and >30 days after the initial EVAR, respectively), and identiﬁed predictors
associated with delayed rupture.
Results: The overall follow-up rate was 92%, and the median follow-up was 2.7 years (interquartile range, 1.2-4.4 years) in
these 1736 EVAR patients. We identiﬁed 20 patients with ruptures; 70% were male, the mean age was 79 years, and mean
AAA size at the initial EVAR was 6.3 cm. Six patients underwent initial EVAR for rupture (n [ 2) or symptomatic
presentation (n [ 4). Of the 20 post-EVAR ruptures, 25% (ﬁve of 20) were early, all occurring within 2 days after the
initial EVAR. Of these ﬁve patients, four had intraoperative adverse events leading directly to rupture, with one type I and
one type III endoleak. Of the ﬁve early ruptures, four patients underwent endovascular repair and one received repair with
open surgery, resulting in two perioperative deaths. Among the remaining 15 patients, the median time from initial
EVAR to rupture was 31.1 months (interquartile range, 13.8-57.3 months). Most of these delayed ruptures (10 of 15)
were preceded by AAA sac increases, including three patients with known endoleaks who underwent reintervention.
At the time of delayed rupture, nine of 15 patients had new endoleaks. Among all 20 patients, six patients did not
undergo repair (all delayed patients) and died, nine underwent repeated EVAR, and ﬁve had open repair. For patients
who underwent repair for delayed rupture, mortality at 30 days and 1 year were 44.4% and 66.7%, respectively. Multi-
variable Cox regression analysis identiﬁed age 80 to 89 (hazard ratio, 3.3; 95% conﬁdence interval, 1.1-9.4; P[ .03), and
symptomatic or ruptured initial indication for EVAR (hazard ratio, 7.4; 95% conﬁdence interval, 2.2-24.8; P < .01) as
signiﬁcant predictors of delayed rupture.
Conclusions: Rupture after EVAR is a rare but devastating event, and mortality after repair exceeds 60% at 1 year. Most
delayed cases showed late AAA expansion, thereby implicating late loss of seal and increased endoleaks as the cause of
rupture in these patients and mandating vigilant surveillance. (J Vasc Surg 2014;60:1146-53.)Endovascular aortic aneurysm repair (EVAR) was ﬁrst AAA rupture is a dreaded but known complication af-
described1 in 1991 and has since become the standard of
care for treatment of abdominal aortic aneurysm (AAA).
Multiple trials have shown excellent short-term outcomes
of EVAR compared with traditional open AAA repair,2-7
but the superiority of long-term results has yet to be deter-
mined. Graft durability remains a chief concern, and life-
long radiographic surveillance has been considered
mandatory to detect treatable complications such as endo-
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EVAR based on a large, multicenter registry over a 10-
year period.14 The purpose of the current study was to
characterize early and delayed rupture after EVAR and to
identify factors associated with delayed rupture after
EVAR in the community setting.
METHODS
Kaiser Permanente Northern California (KPNC) is a
large, integrated health care delivery system caring for
more than 3 million people who are broadly representative
of the local and statewide population. The KPNC Institu-
tional Review Board approved a retrospective review of
1736 EVARs performed by clinicians from 17 KPNC med-
ical centers from 2000 to 2010 with waiver of consent. Rele-
vant clinical data were prospectively collected by trained
research nurses, with December 31, 2010, as the last
follow-up date. Baseline preoperative demographic and clin-
ical characteristic data including sex, age, race and/or
ethnicity, AAA sac size (hereafter termed aneurysm size),
comorbidities, smoking status, and statin history were
collected from digitized health records. Device type and
operative details were collected from the operative report
and device entry forms. Decisions regarding indications
for surgery, suitability for endovascular repair, device type,
and need for secondary intervention were made at the
discretion of the operating surgeon. Data from the follow-
up period such as rupture, aneurysm size, endoleak, reinter-
vention, and mortality were also recorded in our registry.
Postoperative surveillance varied across medical centers
(no standardized post-EVAR protocol existed during the
study period); however, patients generally received a
computed tomography (CT) scan 1 month postoperatively
and then at regular intervals (usually every 6 to 12 months
depending on the clinical scenario). EVAR in patients who
presented with ruptured or symptomatic aneurysms at the
preoperative CT scan was characterized as “urgent.” All
other EVAR was categorized as “elective.” Detailed medi-
cal record review was conducted by the study investigators
to conﬁrm the patients who had a rupture event after the
initial EVAR and their clinical characteristics of interest,
including history of endoleak, aneurysm size, intervention
before rupture, types of repair for rupture, and complica-
tions (eg, cardiac, pulmonary, renal, gastrointestinal, infec-
tious) after rupture.15
Our primary outcome measures were the incidence and
timing of rupture after the initial EVAR. Rupture after
initial EVAR was categorized into two groups: early and
delayed. Early ruptures were those that occurred in the im-
mediate perioperative period (within 30 days) after initial
EVAR; other ruptures were categorized as delayed. Sec-
ondary outcomes included change in aneurysm size over
time, presence and type of endoleak, and the need for addi-
tional intervention.
Statistical methods. Differences in age and aneurysm
size at the initial EVAR were compared between the early
and delayed rupture groups using the t-test. Comparisons
of demographic and clinical variables including sex,treatment of rupture, aneurysm size expansion at the
time of rupture, and overall mortality at 30 days and
1 year between the early and delayed rupture groups
were evaluated using c2 tests or Fisher exact tests. Before
determining the potential risk factors associated with
delayed rupture, we performed a bivariate analysis
comparing the delayed rupture group and patients without
rupture (henceforth called “no rupture group”) using c2
tests or Fisher exact tests for categorical variables (demo-
graphic: sex; at the initial EVAR: age groups, urgent vs
elective initial EVAR, comorbidities, history of statin treat-
ment, and smoking status; intraoperative: bifurcated graft,
adjunctive maneuver, and endoleak) and nonparametric
Wilcoxon Mann-Whitney tests for nonnormally distrib-
uted continuous variables (age and aneurysm size at the
initial EVAR). Because of the small number of patients
with delayed rupture, a stepwise Cox proportional hazards
model was used to identify risk factors of delayed rupture in
15 patients compared with 1716 with no rupture. The
signiﬁcance level to enter and remain in the model was set
at P < .05. All analyses were performed using SAS 9.3 (SAS
Institute Inc, Cary, NC) with the threshold of signiﬁcance
set at P < .05.RESULTS
During the study period, 1736 EVARs were per-
formed. The overall follow-up rate was 92%, and the me-
dian follow-up was 2.7 years (interquartile range [IQR],
1.2-4.4 years). Twenty cases of rupture after EVAR
(1.2%) were identiﬁed, including 5 that occurred within
30 days (“early” rupture) and 15 cases occurring after
30 days (“delayed” rupture).
Seventy percent of ruptures occurred in male patients.
In patients with ruptures, mean age and aneurysm size at
the time of initial EVAR were 79 6 9.1 years and 6.3 6
0.7 cm, respectively (Table I). Six patients underwent
initial EVAR for urgent repair, including two for ruptured
AAA and four for symptomatic AAA; the remaining 14 pa-
tients had elective repair (Table I).
Demographic characteristics and complications of
patients with early ruptures. Three of the ﬁve patients
with early rupture were male, the mean age of patients
was 78.2 6 10.8 years, and the mean aneurysm size was
6.0 6 0.6 cm at the time of initial EVAR (Table I). All
ﬁve cases were performed in the second half of the study
period (2006-2010). All of the ruptures occurred within
2 days of the initial EVAR. Two of these patients were
noted to have intraoperative endoleaks (one type I and one
type III; Table II), which were successfully treated during
the initial EVAR with additional angioplasty and cuff
placement, respectively. Two patients died within 30 days
of rupture, of which one patient had a known ruptured
AAA at the time of EVAR repair; the other was taken back
to the operating room on the day of EVAR and found to
have a large type I endoleak which was treated with an-
gioplasty. All ﬁve patients experienced signiﬁcant post-
operative complications (Table III).
Table II. Demographic and clinical characteristics and mortality in patients with early (perioperative) aneurysm ruptures
Patient No. Operative indicationa EVAR devicea AAA Diameter, cma Endoleak typeb Repair typeb Mortality at end of follow-up
1 Elective Medtronic 5.8 I EV Died within 30 days
2 Elective Zenith 5.2 None EV Died within 1 year
3 Symptomatic AAA Gore 6.2 None EV Died within 30 days
4 Elective Gore 6.0 None OR Alive
5 Ruptured AAA Medtronic 6.8 III EV Alive
AAA, Abdominal aortic aneurysm; EV, endovascular; EVAR, endovascular aortic aneurysm repair; OR, open repair.
aAt initial EVAR. Devices from Medtronic Vascular, Santa Rosa, Calif; Cook Zenith, Bloomington, Ind; and W. L. Gore & Associates, Inc, Flagstaff, Ariz.
bAt time of AAA rupture.
Table I. Demographic and clinical characteristics of 20 patients with early and delayed rupture after initial endovascular
aortic aneurysm repair (EVAR)
Characteristic Total Early (n ¼ 5) Delayed (n ¼ 15) P
Preoperative
Age at initial EVAR, years .84a
Mean 6 SD 79.0 6 9.1 78.2 6 10.8 79.2 6 8.9
Median (IQR) 81 (72-87) 81 (73-87) 81 (72-87)
Male sex 14 (70) 3 (60) 11 (73) .61
AAA size, cm .29a
Mean 6 SD 6.3 6 0.7 6.0 6 0.6 6.4 6 0.7
Median (IQR) 6.2 (5.9-6.8) 6.0 (5.8-6.2) 6.2 (5.9-7.0)
Urgent initial EVAR 6 (30) 2 (40) 4 (27) .61
Treatment and/or repair of rupture .15
None 6 (30) 0 (0) 6 (40)
Open 5 (25) 1 (20) 4 (27)
Endovascular 9 (45) 4 (80) 5 (33)
Aneurysm size expansion at time of rupture 10 (50) 0 (0) 10 (67) .03
Mortality
Overall
30 days 11 (55) 2 (40) 9 (60) .62
One year 15 (70) 3 (60) 12 (80) .56
If underwent repair
30 days 6 (43) 2 (40) 4 (44) >.99
One year 9 (64) 3 (60) 6 (67) >.99
AAA, Abdominal aortic aneurysm; IQR, interquartile range; SD, standard deviation.
Data are presented as number (%), except where otherwise stated.
aComparison result using t-test.
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patients with delayed ruptures. Among the remaining 15
patients, the median time from initial EVAR to rupture was
31.1 months (IQR, 13.8-57.3 months). The mean age of
these patients at the initial EVARwas 79.26 8.9 years, initial
mean AAA size was 6.4 6 0.7 cm, and 73% were male
(Table I). One patient had a known ruptured AAA, and
three patients underwent initial EVAR for symptomatic
indications. Three patients had unplanned adjunctive
maneuvers performed at the time of initial EVAR, including
a renal snorkel/cuff placement for a type I leak, an iliac stent
for an arterial dissection, and an aortic cuff for a type I leak.
Known previous endoleak and/or reintervention.
As shown in Table IV, three of the 15 patients with delayed
rupture had known persistent endoleaks before rupture
(one patient with a presumed type I endoleak, two patients
with presumed type II endoleaks). All three patients
underwent prerupture interventions. The ﬁrst patient had a
possible type I vs type II leak seen on CT scan and
underwent a diagnostic arteriogram that conﬁrmed a type
Ia leak with type II leak outﬂow. The patient declinedfurther intervention and shortly after presented with a fatal,
untreated rupture. The second patient had a persistent type
II leak with sac growth despite coil embolization of lumbar
vessels and subsequent direct sac injection of cyanoacrylate
glue and embolization coils. On open exploration after
rupture, she was found to have a type III leak and died
intraoperatively. The third patient presented with a stable
rupture from a presumed type II leak. On open explora-
tion, slight suture-hole graft bleeding was noted, and a
large inferior mesenteric artery was ligated, because this
was presumed to be the causative agent. The patient was
subsequently re-explored for persistent hemodynamic
instability, and the endograft was relined to treat a pre-
sumed type III leak. The patient had satisfactory results
from a surgical standpoint but subsequently died 40 days
after initial rupture because of multiorgan failure.
Endoleak and aneurysm size at the time of
rupture. At the time of delayed rupture, 12 of 15 patients
were found to have endoleaks (six type I leaks, two type I/
II, one type I/III, one type II/III, two type III; Table IV).
Of the 12 patients with endoleaks at the time of rupture,
Table III. Complications after repair within 30 days in
20 patients who had rupture after initial endovascular
aortic aneurysm repair (EVAR)
Complication, No.
Early group
(n ¼ 5)
Delayed group
(n ¼ 10)a
Cardiac 1 2
Cardiac arrest (not attributable
to another complication)
1 0
Unknown cardiac complication 0 2
Pulmonary 2 4
Respiratory failure requiring
prolonged mechanical ventilation
2 2
Unknown pulmonary complication 0 2
Renal 3 2
Acute renal failure 3 1
Unknown renal complication 0 1
GI: ischemic colitis 1 0
Infectious 3 3
Pneumonia 1 1
Clostridium difﬁcile 1 0
Sepsis 1 0
Unknown infectious complication 0 2
Other 2 3
Paraplegia 1 0
Graft limb thrombosis requiring
fem-fem bypass
1 0
Hematoma requiring evacuation 0 2
Multiorgan dysfunction 0 1
GI, Gastrointestinal.
aFive patients in the delayed group did not undergo repair and were not
included in this table: one patient did not have complication data available
for analysis; three patients had incomplete data available; and one patient
died from exsanguination during surgery.
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been identiﬁed before rupture. Three of these newly
diagnosed leaks occurred in the setting of graft migration.
The remaining three patients did not have conﬁrmed
endoleaks at the time of rupture. Of these three, one pa-
tient was demonstrably free of any endoleak during
follow-up, but the available electronic medical records
and imaging studies did not specify the perirupture endo-
leak status of the remaining two patients in the delayed
group.
Of the 15 patients who presented with delayed rupture,
10 patients (66.7%) experienced aneurysm size expansion
before rupture (Table I). The remaining ﬁve patients had
discernible sac shrinkage after the initial EVAR.
Treatment of rupture and mortality. Of the 20 pa-
tients who presented with rupture after EVAR, six patients
(all with delayed ruptures) did not undergo repair because
of prohibitive risk and/or family decision, and all of these
patients died. The remaining 14 (70%) patients underwent
repair (nine endovascular revisions and ﬁve open repairs).
Of the ﬁve early ruptures, four underwent endovascular
repair and one was repaired with open surgery, resulting
in two perioperative deaths. For patients who underwent
repair, overall mortality at 30 days and 1 year were 42.9%
and 64.3%, respectively (Table I). Mortality rates were
similar between the patients with early and delayed rupturewho underwent repair (40% vs 44.4%, respectively, at
30 days, and 60% vs 66.7% at 1 year).
Complications after repair. Following repair after
rupture, all but one of the 14 patients had major complica-
tions, including cardiovascular complications (4 of 14), res-
piratory complications (7 of 14), renal complications (6 of
14), infectious complications (7 of 14), gastrointestinal
complications (6 of 14), and other signiﬁcant complica-
tions (8 of 14; Table III).
Risk factors for delayed rupture. In Table V, the
results of the bivariate analysis comparing the delayed
rupture and no rupture groups are summarized. Of the
variables included in the bivariate analysis, the stepwise Cox
regression analysis identiﬁed age 80 to 89 years at the initial
EVAR (hazard ratio, 3.3; 95% conﬁdence interval, 1.1-9.4;
P ¼ .03), and symptomatic or ruptured AAA operative
indication at the initial EVAR (hazard ratio, 7.4; 95%
conﬁdence interval, 2.2-24.8; P < .01) as signiﬁcant pre-
dictors of delayed rupture.
Surveillance patterns in delayed rupture patients.
Of the 15 patients with delayed rupture, the median time
from the last imaging study to rupture was 4.1 months
(IQR, 1.4-8 months) (individual values can be seen in
Table IV). Imaging study follow-up averaged 1.5 studies
per person-year from the time of the initial EVAR to
rupture.DISCUSSION
EVAR is associated with a shorter hospital stay and
decreased short-term morbidity than traditional open
repair.2-6,16,17 Long-term graft durability, however, re-
mains a concern, and problems such as endoleak, device
migration, and device failure might require adjunctive pro-
cedures to prevent aneurysm expansion. Of even greater
concern is the potential for AAA rupture, which might
occur in the setting of one of these other complications
or might occur without warning in an aneurysm that ap-
pears to have been adequately excluded. Our study reveals
that age 80 to 89 years at the initial EVAR and a symptom-
atic or ruptured aneurysm as the initial indication for
EVAR are signiﬁcant predictors of delayed rupture.
Only a few reported case series of ruptures after EVAR
have been published, most of which are clinical trial sum-
mary reports or data from international registries.8-12,18-20
The EVAR trial data from Wyss et al13 have provided the
most comprehensive summary to date. Our rate of delayed
rupture is lower than the published rates from the EVAR
trials.13 The EVAR trials and the current study showed
excellent follow-up (98% EVAR 1, 97% EVAR 2, 92%
our study), and the increased incidence of delayed rupture
noted in the EVAR trials might be because of their longer
duration of follow-up (mean 4.8 years compared with
2.7 years in the current study). In addition, the trial sum-
mary report excluded nonelective cases of EVAR, and in
our series there were six nonelective cases of EVAR that
resulted in rupture: two patients who originally received
surgery for ruptured AAA and four patients who had
Table IV. Demographic and clinical characteristics and mortality in patients with delayed aneurysm ruptures after surgery
Patient
No.
EVAR time
periodsa
EVAR
devicea
Time until
rupture,
monthsb
Time from
last study
to rupture,
months
Aneurysm
size
expansionb
Previous
endoleak
Previous
reintervention
Endoleak
typec
Repair
typec
Reintervention
successful
Mortality at
end of follow-up
6 2000-2005 Medtronic 31.1 4.1 No None No None EV N/A Died within 30 days
7 2006-2010 Gore 2.9 2.5 No I or II Yes I and II None No Died within 30 days
8 2000-2005 Medtronic 86.5 20.4 Yes None No I and IIIc EV N/A Died within 1 year
9 2000-2005 Medtronic 87.0 1.3 No None No III EV N/A Alive
10 2000-2005 Zenith 18.2 2.1 Yes II Yes I and II OR No Died within 30 days
11 2006-2010 Medtronic 49.1 5.9 Yes None No Ib EV N/A Alive
12 2006-2010 Gore 20.3 8.0 No None No I None N/A Died within 30 days
13 2000-2005 Zenith 57.3 9.7 Yes None No I None N/A Died within 1 year
14 2006-2010 Zenith 30.7 0.1 Yes II Yes II and III OR No Died within 1 year
15 2000-2005 Zenith 13.8 3.5 No None No I None N/A Died within 30 days
16 2000-2005 Medtronic 60.4 4.1 Yes None No N/A None N/A Died within 30 days
17 2000-2005 Medtronic 39.7 4.5 Yes None No I EV N/A Alive
18 2006-2010 Zenith 2.4 0.6 Yes None No N/A None N/A Died within 30 days
19 2000-2005 Zenith 6.9 1.4 Yes None No III OR N/A Died within 30 days
20 2000-2005 Medtronic 42.6 20.7 Yes None No Ib OR N/A Died within 30 days
AAA, Abdominal aortic aneurysm; EV, endovascular; EVAR, endovascular aortic aneurysm repair; N/A, not applicable; OR, open repair.
Most EVARs (93.2%) in the entire cohort were performed with Cook Zenith (48.4%; Cook Inc, Bloomington, Ind), Medtronic Aneurx (19.5%; Medtronic
Vascular, Santa Rosa, Calif), or low-permeability Gore Excluder (25.2%; W. L. Gore & Associates, Inc, Flagstaff, Ariz).
aAt initial EVAR.
bFrom initial EVAR to AAA rupture.
cAt time of AAA rupture.
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studies have shown even lower rates of rupture after
EVAR.19,20
Five of our patients experienced rupture in the imme-
diate perioperative period; four of these patients underwent
endovascular repair and one underwent open repair.
Further review of these cases suggested that technical difﬁ-
culties and signiﬁcant intraoperative events preceded these
ruptures, implying that we should be able to reduce the
rate of these rare events further with more meticulous pre-
operative planning, improved technical performance, and
the introduction of new graft designs.19
Delayed ruptures can be separated into two groups: pa-
tients who had known endoleak before rupture and those
who did not. Three of our 15 patients with delayed rup-
tures had known persistent endoleaks before rupture, and
all had undergone intervention for these endoleaks. Nine
additional patients had newly detected endoleaks at the
time of rupture. Three patients had neither an endoleak
detected before rupture nor an endoleak identiﬁed at the
time of rupture. However, two of these patients had known
aneurysm expansion in the absence of detectable endoleak,
and it could be presumed that there was a contributory but
undetected endoleak present, although the presence of
these leaks was not conﬁrmed using imaging after rupture.
It is interesting to note that there were only two patients
who presented with aneurysm rupture with apparent pre-
operative evidence of isolated type II endoleak. On repair
however, one patient was found to have a previously undi-
agnosed type I leak and the other patient had a previously
unknown type III leak. Thus, no ruptures in this series
could be attributed to an isolated type II leak.
Our multivariable analysis demonstrated that age 80 to
89 years at the initial EVAR and urgent initial repair wereindependently associated with delayed rupture. Age has
previously been shown to be associated with rupture after
EVAR.13 Our initial urgent repairs (107 of 1736 EVARs)
were all done for symptomatic or ruptured aneurysms,
and 78% were $5.5 cm, supporting the generally agreed-
on threshold of 5.5 cm as an indication for elective repair.
If more aneurysms are electively rather than urgently or
emergently repaired, the delayed rupture rate might poten-
tially decrease. Unlike Wyss et al,13 we did not ﬁnd previ-
ous complications or interventions to be associated with
rupture after EVAR. This might be because of the small
proportion of post-EVAR ruptures or the need for a
lengthier follow-up period.
Short-term mortality remained high even in patients
who were deemed stable enough to undergo emergency
repair. Overall 30-day and 1-year mortality were 42.9%
and 64.3%, respectively, and among those who underwent
repair after delayed rupture, 30-day and 1-year mortality
were 44.4% and 66.7%, respectively. Wyss et al13 found
an overall 30-day and 1-year survival of 33.3% and 14.8%
in the EVAR trials, and 30-day survival of 75% among
those who underwent intervention after rupture. Our
lower 30-day survival in patients who underwent repair
compared with that in the EVAR trials might be because
of the proportionally larger percentage of patients in our
study who elected intervention after delayed rupture rather
than selecting comfort measures only (60% vs 44.4%).
Without long-term anatomic information for the entire
1736-patient EVAR registry, it is difﬁcult to speculate
about the durability of any particular stent graft and its abil-
ity to provide adequate outﬂow and continued aneurysm
exclusion. It is reasonable to assume that as the duration
of follow-up continues to lengthen in this cohort, we will
see an increasing number of late ruptures. At present,
Table V. Baseline preoperative demographic and clinical characteristics of interest of 1731 endovascular aortic aneurysm
repair (EVAR) patients, stratiﬁed according to delayed rupture status (rupture >30 days after initial EVAR) during the
follow-up period
Characteristics Total No rupture (n ¼ 1716) Delayed rupture (n ¼ 15) Pa
Male sex 1498 (86.5) 1487 (86.7) 11 (73) .13
Age, years .10b
Mean 6 SD 74.9 6 7.9 74.9 6 7.9 79.2 6 8.9
Median (IQR) 76.0 (70.0-81.0) 76.0 (70.0-81.0) 81.0 (72.0-87.0)
Age group, years .06
#79 1205 (69.6) 1198 (69.8) 7 (47)
80-89 499 (28.8) 492 (28.7) 7 (47)
$90 27 (1.6) 26 (1.5) 1 (7)
Preoperative AAA size, cm <.01b
Mean 6 SD 5.8 6 1.1 5.8 6 1.1 6.4 6 0.7
Median (IQR) 5.6 (5.2-6.2) 5.6 (5.2-6.2) 6.2 (5.9-7.0)
Urgent initial EVAR 105 (6.1) 101 (5.9) 4 (27) .01
Treated with statin 579 (33.5) 573 (33.4) 6 (40) .59
Preoperative embolization 116 (6.7) 115 (6.7) 1 (7) >.99
Coronary artery disease 808 (46.7) 799 (46.6) 9 (60) .30
Diabetes 441 (25.5) 435 (25.4) 6 (40) .23
Hyperlipidemia 1321 (76.3) 1309 (76.3) 12 (80) >.99
Hypertension 1450 (83.8) 1437 (83.7) 13 (87) >.99
Peripheral vascular disease 366 (21.1) 362 (21.1) 4 (27) .54
Current smoker 309 (17.9) 308 (18.0) 1 (7) .49
Bifurcated graft 1481 (85.6) 1466 (85.4) 15 (100) .15
Operative adjunctive maneuver 76 (4.4) 74 (4.3) 2 (13) .13
Intraoperative endoleak 201 (11.6) 199 (11.6) 2 (14) .69
AAA, Abdominal aortic aneurysm; IQR, interquartile range; SD, standard deviation.
Data are presented as number (%), except where otherwise stated. Group percentages might not total 100 due to rounding.
aFor comparisons between the no rupture and delayed rupture groups.
bComparison result using Wilcoxon Mann-Whitney test.
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ment and rupture, and from our series of >1700 patients,
much the same can be concluded about EVAR for mostd
but not alldpatients. However, despite coordinated
follow-up in our integrated system, many of the patients
with delayed rupture presented with new issues related to
their repair, which led to rupture. This would suggest
that more rigorous surveillance of “at-risk” patients is war-
ranted, but “at-risk” is as yet poorly deﬁned. In addition,
despite best practices, two patients had more than 1 year
elapse between imaging studies, implying an interruption
in provider-patient communication. Both of these patients
had an increase in aneurysm size and new endoleaks that
might have been detected in a more timely fashion.
Because our long-term follow-up rate of 92% is high
compared with historical case series, we speculate that in-
stances of missed follow-up likely occur more often than
documented and can lead to undetected adverse outcomes.
Limitations of our study fall into four areas: variation in
practice, lack of initial morphologic data for the entire
EVAR cohort, self-reporting of adverse events, and small
sample size. Despite regionalized surveillance after EVAR
in our health care system, treatment thresholds are not uni-
form among providers and individual surgeons’ decision-
making and practice patterns vary widely. Furthermore,
incomplete initial morphologic data impair our ability to
comment on compliance with instructions for use in our
overall cohort and how it might compare with the rupturedcohort. Although the data were prospectively collected,
adverse events were self-reported, and underreporting is a
possibility. In addition, it is difﬁcult to account for ruptures
possibly occurring outside of our health care system or to
know whether any of the 22 patients (of the entire 1736-
patient cohort) who died after EVAR with no known cause
of death might have experienced ruptures. These represent
possible sources of underreporting in this cohort. Finally,
despite our sizable EVAR registry, rupture after EVAR is
a rare event and the small sample size limits our ability to
draw signiﬁcant conclusions about event occurrence at
this time. Our future work will use device-speciﬁc details
from our large national dataset to identify more sensitive
predictors of rupture and graft durability after EVAR.CONCLUSIONS
Rupture after EVAR is a rare event but is associated
with signiﬁcant morbidity and mortality. In our large
contemporary series of community-based practice encom-
passing elective and urgent EVAR, most patients with
delayed ruptures showed late aneurysm size expansion
with concomitant undetected endoleak, suggesting
device-related failure as the most likely etiology. Vigilant
and continued radiographic surveillance is crucial postoper-
atively, especially in troublesome or suboptimal cases, and
further studies are needed to identify more sensitive predic-
tors of rupture after EVAR.
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here we are together again, in Jasper, Alberta. Thanks to the soci-
ety for allowing me to discuss this paper. Congratulations to
Dr Candell on a nice presentation.
I had several initial impressions when reading this manuscript.
Much like some of the work from the Vascular Study Group of
New England, and actually with a co-author from a member of
the VSGNE, we have yet another example of a large Integrated
Regional Health Care System collecting their experience to pro-
vide a large number of patients and present information that would
potentially help guide therapy. Unfortunately, I don’t feel as if this
study really adds much to what we already know.
There were 1736 patients treated with endovascular aortic
aneurysm repair (EVAR) over a 10-year period at 17 Kaiser sites.
When you do the math, that is 10 EVARs per year per site e a
modest experience at best. Delayed rupture occurred in only 20
patients, with six of those patients being treated for rupture or
symptoms to begin with. That left only 15 patients with delayed
rupture after 30 days for an incidence of 0.8%. So, we know that
this is indeed a rare event! We also see that patients who experi-
enced delayed rupture were old and the majority of their sacs
increased in size over time, leading to multiple reinterventions.The authors sought to deﬁne what factors, if any, contributed to
this rare event.
Sadly, no data on device, instructions for use (IFU) adher-
ence, oversizing, or anatomical suitability features were collected.
All we can gather from this data set is that old age and rupture
at presentation were associated with increased risk of delayed
rupture. We already knew that!
The conclusion is that we need to follow our patients and be
diligent. Okay. So, does that mean that you’re not going to treat
old people or those presenting with rupture? Thankfully, according
to this dataset, 99% of patients will not experience this morbid and
potentially mortal event.
Another interesting ﬁnding from this decade-long experience
was that no ruptures were due to type II endoleaks, sustaining our
belief that most type IIs are benign AND when associated with an
increase in sac size, probably really aren’t type IIs and are more
likely types I and III.
So, I have the following three questions for the authors:
1. How will this information be used to change practice within
the Kaiser system? After all, isn’t that why we do these studies?
Is this outcome data available to ALL vascular interventionists
within the Kaiser system?! In other words . how does this
JOURNAL OF VASCULAR SURGERY
Volume 60, Number 5 Candell et al 1153information get back to the guy in the trenches so that he or
she can change his or her own practice?
2. With an average of only 10 EVARs per site per year, has there
been any discussion about regionalization of care for EVAR in
Northern California? Were some event rates higher at certain
sites suggesting treatment outside of device IFUs by some
“aggressive” physicians? Three of 15 delayed rupture patients
had additional procedures at the index operation including
snorkels and cuffs for type I endoleaks; this suggests that treat-
ment outside the device IFU for short neck aneurysms was
associated with a higher delayed rupture event rate.
3. Finally, you must tell us what the graft types and anatomical
features were for all that had delayed rupture. It is astonishing
to me that these data were not reported with Kaiser’s reputa-
tion of such a thorough electronic medical record! Come on,
guys; it’s only 20 patients! I realize that you don’t have this
information, but this would indeed be useful data. What was
the frequency of delayed rupture over time? Has this decreased
over the past decade in the authors’ experience?
Thank you for sending me the manuscript at least 1 week
before the meeting, and I look forward to your comments.
Dr Leah Candell. Thank you, Dr Starnes, for your interesting
comments, which speak to many issues regarding a retrospective
registry. It is our goal to understand outcomes within our inte-
grated health system. In order to do so, we must improve our
data acquisition to inform our conclusions.
With respect to your ﬁrst comment about the modest experi-
ence across facilities: in Kaiser Permanente’s early experience with
EVAR, sites and clinicians were clustered around the neighboring
academic centers. As experience was gained, the case volume and
number of operating surgeons increased greatly throughout the
second half of the study period. This is reﬂected in the mean
follow-up of 2.7 years despite our 10 years of experience.
Second, our device registry, created more than a decade ago,
did not require anatomic information to be collected other than
abdominal aortic aneurysm size. Although we had some promising
data about IFU adherence from a subset of patients, this was by nomeans standard and comprehensive, which limited our ability to
analyze this important topic. This is something we will address
with our new national stent registry.
We appreciate your comments about the observation of type II
leaks, and we agree that they may represent a benign occurrence
after EVAR. We looked into this in more detail and presented
these ﬁndings at the VESS meeting in Boston, in June 2014.
Our responses to your three speciﬁc questions follow:
1. We agree that registry information should be used for practice
improvement. This is central to any system’s mission to pro-
vide efﬁcient and safe care. Currently, Kaiser Permanente reg-
istry reports are tabulated quarterly with several outcomes
reported at the national, regional, and more granular levels.
In addition, clinicians may request a breakout report of certain
characteristics or outcomes. Similar to what is done in other
registry domains, we are utilizing this ability to establish
more-efﬁcient surveillance protocols, to more appropriately
select patients for intervention, and to improve processes
such as percutaneous access.
2. As stated above, currently most sites that perform EVAR have
higher operative volumes than they did in the early era of
EVAR. There has been an evolution into a spoke-hub model
in which complex thoracic and abdominal aortic interventions
are performed in a few selected centers. This is certainly true
with the hybrid endovascular procedures as well as fenestrated
EVAR.
3. We agree that information on graft type and anatomical fea-
tures is vital for understanding the rare phenomenon of
delayed rupture. This content was removed from the original
manuscript due to privacy concerns, but after further discus-
sion, was added into the ﬁnal manuscript that will be pub-
lished. The limited availability of archived computed
tomography data allowed us to make only general statements
about IFU adherence and was not sufﬁcient to enable us to
comment on graft and anatomic interactions.
We thank Dr Starnes for his review of our paper and his
thoughtful comments.
